InvestorsHub Logo
Followers 2
Posts 119
Boards Moderated 0
Alias Born 09/20/2017

Re: Glider549 post# 1941

Tuesday, 09/24/2019 2:22:57 PM

Tuesday, September 24, 2019 2:22:57 PM

Post# of 2676
Well, not really unbelievable. OVID's report yesterday now means that there are three competitors in the DEE space all with products that are basically competitive. GWPH with hemp derived CBD, Zyne with synthetic CBD and OVID with its proprietary molecule. OVID has the smallest market cap. So, it goes up, and GWPH and Zyne go down. However, Zyne has other things going for it which will support its recovery in due course. These are 1) synthetic CBD (pure, low cost), 2) FX, 3) ASD and 4) 22Q. Zyne is still the lead horse in this race, I believe.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News